Status:
UNKNOWN
Comparison of the Effects of Nicardipine and Remifentanil on Surgical Visual Field
Lead Sponsor:
Erol Karaaslan
Conditions:
Other Complications of Surgical and Medical Procedures
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In the present study, the purpose was to compare the effects of Nicardipine and Remifentanil on surgical visual field and hemodynamic parameters in microscopic tympanomastoidectomy cases with Controll...
Detailed Description
The visibility of the surgical field provides many advantages (e.g., preventing possible complications and reducing the duration of surgical application). In microsurgery performed in a closed and nar...
Eligibility Criteria
Inclusion
- ASA I-II patients of both sexes,
- aged 18-65 years,
- scheduled for tympanomastoidectomy and decided to perform CH,
Exclusion
- hypertension,
- anticoagulant medication,
- pregnancy
- major hepatic,
- renal,
- cerebral, or cardiorespiratory dysfunction,
- neurological or psychiatric disease
- ASA 3-4,
- Body Mass Index BMI≥35 kg/m2,
- difficult intubation was considered (Mallampati score 3-4, a thyromental distance less than 6 cm, maximum mouth opening less than 3 cm),
- the number of intubation attempts more than two, cases with allergies to any of the agents used in the study
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06130527
Start Date
November 30 2023
End Date
December 30 2023
Last Update
November 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.